Rheumatology Market Analysis and Reports | Poland Conference Series

Market Analysis - Rheumatology 2018

The conference highlights the following topics

•      Rheumatic Disorders

•      Rheumatoid Arthritis

•      Soft Tissue Rheumatism

•      Therapies for Rheumatic Disorders

•      Rheumatology Practices

•      Diagnosis for Rheumatology Disorders

•      Arthritis

•      Osteoarthritis            

•      Orthopedic Trauma

•      Orthopedic Biomechanics

•      Medical Instruments in Orthopedics and Rheumatology

•      Lupus

•      Pediatric Rheumatology

 

Rheumatology described as the study of rheumatism which focused on the diagnosis and treatment of rheumatic diseases which mainly affects the joints, muscles and the connective tissues around the joints and bones. Nowadays it is a common health problem in the developing world. Around 100 different diseases have been classified within the Rheumatology. These rheumatics’ disease also links with the cardiovascular diseases such as   myocardial infarction and strokes and affects the other parts of the body like lung, kidneys nervous system, skin etc. The disease Rheumatoid Arthritis affects approximately 1% of the total world population in the form of diseases. A complete understanding of the pathophysiological process underlying rheumatic diseases will initiate the development of new drugs.

Market Analysis and Case study of Rheumatic Diseases

Rheumatic’s diseases are cause behind severe long term pain and physical disabilities. According to survey in Europe 20-30 % of adults are affected at any one time. According to British Society of Rheumatology around 10 million people in UK suffer from arthritis of which almost 0.7 million have Rheumatoid Arthritis. Juvenile Idiopathic Arthritis which is rheumatic disorder in the children up to the age of 16, JIA cause joints pain, swelling, warmth, tenderness and stiffness that last for at least 6 weeks. Around 12000 children in UK suffer from idiopathic disorder. According to CDC (Centers for Disease Control and Prevention), An estimated 78 million adults at the age of 18 and older will have diagnosed with arthritis by the year 2040 as compared with the 52 million adults in 2010-2012. Two third of those with arthritis will be women.

Highlighting some of the common type of Rheumatic disorders

  • Out of every 1 lakh people 41 are diagnosed with RA.
  • The prevalence varies between 0.3% and 1% and is more common in women and in developed countries, Hormones in both play a role in either preventing or triggering it.
  • RA generally starts at the age of 30-60 and somewhat later in life in men. However RA can strike at any age-even small children can get it. Around 3 lakh children have the juvenile form of rheumatic disease.
  • By the year of 2030, at least 50% of patients suffer from rheumatic diseases in developing countries are unable to hold down a full time job.

The effect of arthritis on individual is significant. About 22.7 million of the 52.5 million adults with arthritis report the restrictions in their daily work activities due to the arthritis. Functional limitations in daily work activities are common in adults with arthritis; 40% report it is “very difficult” to perform 1 of 9 important daily functional activities. Figure 1 shows the occurrence of certain functional limitations. Impairment in the ability to perform routine activities may interfere with the ability of people to work, function in their community, or care for their family.

Fig.1 Functional limitations among patients with Arthritis

Note:-Functional limitation describe very difficult to cannot do level for the activities mentioned in fig.1

Physical activity and exercise plays a major role in giving a benefit to the people with arthritis by improving pain, function and physical and mental level, many patients reports no free time for physical activities.  24% of adults with arthritis report no leisure time physical activity, a higher proportion in comparison to the adults without arthritis. (18.6%) (Age-adjusted prevalence estimates). The individuals with low level of physical activities have a risk of inactivity associated diseases like cardiovascular, diabetes and functional limitations with obesity.

Figure 2Age- Adjusted Occurrence of Physical Inactivity* among Adults with and without Arthritis

According to the data collected from the Spanish Society for Rheumatology there was new cases of hip fracture within a 14 years period. The increment observed was mainly 64% in women in comparison to 19% in men.  13% of patients suffered from a fracture die after 3 months which rises to 38% after 2 years. 45% of patients suffer from vertebral fracture bear functional damage and 50% are bothering partial or total disability. 

Figure 3.

According to the survey of SPANISH REGISTRY OF ADVERSE EVENTS OF BIOLOGICAL THERAPIES IN RHEUMATIC DISEASES out of 6,754 patients in the hospitals in Spain 56% of those were suffering from Rheumatoid Arthritis, 12% from Ankylosing Spondylitis, another 12% from Psoriatic Arthritis and Juvenile Idiopathic Arthritis counted to 4.9 %.  

 

Figure 4.

Rheumatoid arthritis, psoriatic arthritis, osteoarthritis (OA), Systemic Lupus Erythematosus (SLE), Fibromyalgia (FM) and Ankylosing Spondylitis (AS) are very common among adults. The incidence and prevalence of these rheumatic diseases are high. The existence prevalence of RA in adults is 3.4 percent and it is highly associated with age. Whereas the prevalence is only one percent of adults under the age of 30 and 6.25 % in adults over the age of 70. The lifetime prevalence of rheumatic diseases at the age of 40 in women tends to be higher in comparison to men and becomes twice than as in men after the age of 70. The burden originate by Rheumatic diseases is high. Not only they impair function and quality of life but also the important cause of chronic health problems (approx. 40 percent), long-term affliction (approx. 50 percent) and short-term affliction (approx. 30 percent) compared to the other common diagnoses. The number of people with arthritis and associated diseases is projected to 67 million by 2030.  

Highlighting some of the common type of Rheumatic disorders

Rheumatoid Arthritis

  • Out of every 1 lakh people 41 are diagnosed with RA.
  • The prevalence varies between 0.3% and 1% and is more common in women and in developed countries, Hormones in both play a role in either preventing or triggering it.
  • RA generally starts at the age 30 to 60 and somewhat later in life in men. However RA can strike at any age-even small children can get it. Around 3 lakh children have the juvenile form of rheumatic disease.
  • By the year of 2030, at least 50% of patients suffer from rheumatic diseases in a developing countries are unable to hold down a full time job.

Osteoarthritis

  • Osteoarthritis is a kind of degenerative joint disorder and one of the ten most disabling disease in developed countries.
  • The prevalence of osteoarthritis is increasing indefinitely with age. Men are more affected as compare to women among those ages of ˂45 years, whereas women are more frequently affected among those aged at ˃55 years.
  • A recent study found that women who have menstruation at the age of 11 or earlier had a 9-15% higher risk of hip/knee replacement surgery as compare to adults.
  • On account of worldwide estimation 9.6% of men and 18.0% of women aged over 60 years have symptomatic osteoarthritis.
  • 80% of patients with osteoarthritis will have limitations in movement, and 25% are not able to perform their daily activities of life. 

Osteoporosis

  • Osteoporosis is a common metabolic bone disease characterized by low bone mass and deterioration of bone tissue.
  • Worldwide Annually more than 8.9 million fracture caused by osteoporosis.
  • Around 75 million people affects from osteoporosis in Europe, USA and Japan.
  • Worldwide at over the age of 50 years 1 in three 3 women experiences a osteoporotic fracture as will 1 in 5 men over the age of 50 years.
  • By the 2050, the incidence of hip fracture project to increase by 310% in men and 240% in the women as compare to the rate of 1990.

Spinal Disorders

  • Every year worldwide between 2.5 L AND 5 L people suffered a spinal cord disorders.
  • Around 80–85% of back pain episodes have no known cause.
  • Low back pain is the very common health problem worldwide and a major cause of disabilities affecting the daily work activities. It affects people of all ages from children to elderly.
  • 80% persons at any point in their life experiences spinal cord disorder
  • Many factors, physical, psychological and occupational, contribute to the occurrence of back pain.

Severe limb trauma 

  • In developed countries, serious limb trauma requiring hospitalization arises 50% of the time from falls, 15–20%    from road traffic accidents, and about 20% from machinery and tool usage.
  • The highest rates for limb trauma occur in two distinct age groups: those 5–34 years of age and those over 75    years of age. In the elderly, falls represent the greatest threat for incurring limb injury, while road traffic accidents   present the highest risk factor for adolescents and young adults.

Why Poland?

In Europe, rheumatic diseases ranked at first place amongst chronic diseases. With 0.5 to 1 percent of individuals affected, .It is the most common inflammatory autoimmune disease. Rheumatic’s diseases are cause behind severe long term pain and physical disabilities. According to survey in Europe 20-30 % of adults are affected at any one time. According to British Society of Rheumatology around 10 million people in UK suffer from arthritis of which almost 0.7 million have Rheumatoid Arthritis.

Increasing in the percentage of Rheumatic Diseases in a span of 14 years is an worrying situation to spread awareness and knowledge about the Rheumatic diseases and its preventives. Conferenceseries LLC aim to organize a Rheumatology conferences with a focus to advance the awareness for chronic pain and to reduce the effect of chronic pain in Rome, other European countries and the rest of the world.

 

Why to attend???

Medical doctors, patients and health care providers consider the prevention of Rheumatic diseases as an essential tool to improve the general health status of the population. The proportions of people suffering from the disease are expected to increase in future according a recent statistical survey. According to recent statistics, Rheumatic diseases worldwide will double between 2012 and 2030. Realizing this imperative, Conferenceseries LLC Group is set to organize International Conference on Targeting Rheumatology and Novel Therapeutics this year with a view to enhance research and promote awareness aiming in developing solutions for the challenges encountered. Rheumatology 2018 will comprise of many leading keynote speakers and session speakers who will be delivering their speech on the current research topics of Rheumatic disorders therapeutics, complications related to Rheumatism and other risk factors associated with the disease. The young researchers and the student participants will gain the opportunity to grab the Best Poster Award by presenting their work as a poster presentation and Young Researcher Forum at the Rheumatology meeting.

Major Rheumatology Associations around the Globe

  • American College of Rheumatology
  • British Society for Rheumatology  
  • Rheumatology association of Baltimore,
  • Texas Rheumatology Associates, Texas
  • International League of Associations for Rheumatology
  • Indian Rheumatology association
  • European League against Rheumatism
  • Asia Pacific League of Associations for Rheumatology
  •  African League of Associations for Rheumatology
  • Australian Rheumatology Association
  • Pan American League of Associations for Rheumatology 

Major Rheumatology Associations in Italy

  • Association of sick rheumatic Friuli.
  • Association for the child rheumatic.
  • The Nando and Elsa Peretti Foundation.
  • The Association Children and Adolescent Rheumatic Onlus (ABARTU).
  • Italian Society of Rheumatology (SIR).
  • The European League Against Rheumatism (EULAR).
  • A.P.M.A.R. Onlus, Italian non-profit association of People with Rheumatic Diseases.
  • Padiatric Rheumatology International Trial Organization (PRINTO).
  • AMRI Association for Diseases.

 

Figure 5.

Target Audience: 

Rheumatology conference congregate renowned scientists, surgeons, physicians, young researchers, delegates from industries and communities of talented students in the field of rheumatology and Orthopedics under a single roof and help all to get first hand access to the latest discoveries and research and major innovations of modern rheumatology transforming Rheumatic disease care.


Top Rheumatology associated Hospitals in the world

  • Hospital for Special Surgery, US
  • Johns Hopkins Hospital, Baltimore
  • Cleveland Clinic, Cleveland
  • Mayo Clinic, Rochester
  • UCLA, WESTWOOD
  • SAKRA WORLD Hospital, India

Rheumatology now and in next 10 years

It is important to spread awareness among the people about the Rheumatic disorders. Patients usually refer an Orthopedician in instance of a Rheumatic Disorders.  Rheumatology field has to go a long way  to promote the awareness about the Rheumatic diseases and their effects, therapy and preventions. Research area in the field of Rheumatology and the diseases or disorders has a wide scope to bring out many new prophylactic measure and treatments.

  • Around 10 million people in UK suffer from arthritis of which almost 0.7 million have Rheumatoid Arthritis.
  • Around 12000 children in UK suffer from idiopathic arthritis disorder, which can cause the pain, disability of joints and the conditions that adults experience in  rheumatic conditions.
  • An estimated 78 million adults at the age of 18 and older will have diagnosed with arthritis by the year 2040 as compared with the 52 million adults in 2010-2012.
  • The number of people with arthritis and associated diseases is projected to 67 million by 2030. 

In Spain, Number of rheumatologists for the public health sector increase up to 4.8% in the last seven years, unlike the 2005 study shows the increment of 4.0% over the previous eight years. 

Rheumatology Research Foundation, A major Rheumatology Association provide funds for education and training to rheumatologists and health professionals worldwide. These funds help young investigators to pursue their promising research ideas to support innovative research projects which improve treatments for patients with rheumatic diseases and leads to a cure.

 

 

Grants

Amount

Awarded to

Duration

Innovative Research Award

 

$400,000

Physician Scientists, Health Professional Researchers and Clinicians

2 years

Career Development Bridge Funding
Award: R Bridge

$200,000

Physician Scientists and Health Professional Researchers

2 years

Scientist Development Award

$225,000

Fellows, Early-Career Physicians and
Health Professionals

2-3 years

Clinician Scholar Educator Award

$180,000

Educators

3 years

Lawren H. Daltroy Health Professional Preceptorship

Up to $12,000

Health Professionals pursuing additional training

1 year

Student & Resident ACR/ARHP Annual
Meeting Scholarship

$1,500

Residents, Medical Students and
Graduate Students

1 year

     Student Achievement Award                                      

$750

Medical and Graduate Students

1 year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Conference Series has been a great influence in running international rheumatology meetings for four years and ready to elaborate its spectrum in Asia, America, Europe countries. Conferenceseries successfully conducted past meeting in major cities like San Francisco, Alicante, Baltimore, with great success the meetings again scheduled in three continents. 10th Global Orthopedicians Annual Meeting to be held during July 03-04, 2017 at Kuala Lumpur, Malaysia. Global Orthopdicians meeting on Tennis Elbow is to be scheduled in San Antonio, USA. Rheumatology Congress 2018 planned to be conducted at Atlanta in 2017. 

Conferenceseries LLC is pleased to announce the commencement of the 9th European Congress of Rheumatology, Autoimmunity and Orthopedics on March 12-13, 2018 at London, UK. The theme of the conference is “Expanding the horizons with new controversies in Rheumatology and Orthopedic Diseases.” The purpose of the conference is to elucidate the disease from a number of scientific aspects, present an opportunity to meet and network with renowned Rheumatologists, pharmacists and the allied health professional from around the world and listen to top speakers on new development that will advance the future of Rheumatology.